Canadian approval sought for controversial pain drug.
作者信息
Brown Carolyn
出版信息
CMAJ. 2014 May 13;186(8):571. doi: 10.1503/cmaj.109-4765. Epub 2014 Mar 24.
Abstract
摘要
相似文献
1
Canadian approval sought for controversial pain drug.有争议的止痛药物寻求加拿大批准。
CMAJ. 2014 May 13;186(8):571. doi: 10.1503/cmaj.109-4765. Epub 2014 Mar 24.
2
FDA chief defends Zohydro approval as US states rebel.美国各州纷纷抵制，美国食品药品监督管理局局长为氢可酮缓释片获批一事进行辩护。
BMJ. 2014 Apr 24;348:g2939. doi: 10.1136/bmj.g2939.
3
Chronic pain, addiction, and Zohydro.慢性疼痛、成瘾与羟考酮缓释片（Zohydro）
N Engl J Med. 2014 May 29;370(22):2061-3. doi: 10.1056/NEJMp1404181. Epub 2014 Apr 23.
4
Zohydro approval by food and drug administration: controversial or frightening?食品和药物管理局批准佐氢可待因：有争议还是可怕？
Pain Physician. 2014 Jul-Aug;17(4):E437-50.
5
Approval of New Opioid Raises Concerns.新型阿片类药物获批引发担忧。
Am J Nurs. 2019 Feb;119(2):20-21. doi: 10.1097/01.NAJ.0000553201.28965.89.
6
Extended-release hydrocodone (Zohydro) for pain.用于止痛的缓释氢可酮（佐氢可酮）。
Med Lett Drugs Ther. 2014 Jun 9;56(1444):45-6.
7
REMS; red tape, or a remedy for opioid abuse?风险评估与缓解策略；繁文缛节，还是阿片类药物滥用的补救措施？
J Fam Pract. 2011 Sep;60(9 Suppl):S55-62.
8
FDA Approval of Extended-Release Oxycodone for Children With Severe Pain.美国食品药品监督管理局批准缓释羟考酮用于治疗患有严重疼痛的儿童。
Pediatrics. 2016 May;137(5). doi: 10.1542/peds.2016-0205. Epub 2016 Apr 19.
9
Both Urgency and Balance Needed in Addressing Opioid Epidemic: A Report From the National Academies of Sciences, Engineering, and Medicine.应对阿片类药物流行需兼顾紧迫性与平衡性：美国国家科学院、工程院和医学院的一份报告
JAMA. 2017 Aug 1;318(5):423-424. doi: 10.1001/jama.2017.10046.
10
US bill would force FDA to withdraw approval of new pain drug Zohydro.美国法案将迫使美国食品药品监督管理局撤销新型止痛药物Zohydro的批准。
BMJ. 2014 Mar 17;348:g2195. doi: 10.1136/bmj.g2195.
Zotero 插件